Research compound profile
TB-500
Catalog designation · thymosin beta-4–related synthetic peptide — actin & repair models in literature
TB-500 is a trade / catalog name used in research supply for synthetic peptides that authors and suppliers often discuss alongside thymosin beta-4 (Tβ4) biology—a small actin-binding protein studied in cell migration, cytoskeletal remodeling, and tissue-repair models. Commercial materials may be full-length, fragment, or analog presentations depending on the manufacturer; your vial is defined by the listing, label, and COA, not by this overview. NEXT lists materials for authorized research use only—not for human or veterinary treatment, consumer injection protocols, or compounding for patients.
Compound specifications
Mechanism — research framing
- Actin dynamics: Tβ4-family peptides are widely studied as G-actin–sequestering modules that influence filament assembly in controlled biochemical and cellular assays.
- Cell migration: Publications tie peptide exposure to motility readouts in wound-edge, endothelial, or epithelial models—species, matrix, and dose route matter.
- Angiogenesis & perfusion themes: Some injury models report vascular remodeling endpoints; causal claims outside those protocols are not supported on this page.
- Cardiac / ischemia narratives: Specialized rodent work discusses infarct size or remodeling surrogates; regulatory drug programs, where they exist, are distinct from RUO catalog items.
Areas of research interest (literature)
- Dermal, corneal, or mucosal wound models with histology and tensiometry endpoints.
- Musculoskeletal and tendon/ligament repair readouts in animals (protocol-dependent).
- Hair follicle or epithelial stem-cell assays where migration metrics are primary.
- Combination or “stack” preclinical designs—interaction and batch purity are laboratory concerns.
- Mass spectrometry, HPLC identity, and stability studies for inventory reconciliation.
Peptide regulations & site policy
- RUO: Materials are sold for research use only. They are not drugs, supplements, or cosmetics for human or animal use unless your program holds all required authorizations.
- FDA / FTC: Investigational compounds are not FDA-approved for the uses discussed in lay media. This page is educational; it does not diagnose, treat, cure, or prevent any disease.
- No clinical instructions: NEXT does not provide dosing, reconstitution for injection in humans, cycle advice, or prescribing information.
- Jurisdiction: Import, possession, and use of research peptides are regulated differently by country and state. You are responsible for lawful conduct in your location.
- COA & chain of custody: Batch documentation is provided per catalog policy; storage, handling, and record-keeping are your laboratory’s responsibility.
- Wholesale / retail paths: Volume and institutional purchasing follow B2B membership rules after approval; retail checkout follows discount membership and storefront terms.